Tianjin TEDA Biomedical Engineering Company Limited risk profile
61 Stretched several inputs deteriorating together
Measured 21 October 2026 from 8189.HK's filed statements. Recomputed nightly.
61 (Stretched), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 87 | Acute | Volatile | One-year price volatility — 88.6% |
| Operating pressure | 36 | Normal | Easing | Input-cost exposure — 0.32 |
| Cash conversion | 100 | Acute | Worsening | Capital spending against operating cash — -0.15x |
| Leverage and coverage | 97 | Acute | Stable | Net debt to EBITDA |
| Competitive position | 46 | Elevated | Stable | Operating-margin gap against peers — -1.4 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Basic Materials companies with a risk reading
Linde Plc. 28BHP Group Ltd 24Industria De Diseno Textil SA 20Southern Copper Corporation 13Rio Tinto Group 40Rio Tinto plc 37Newmont Corp 21L'Air Liquide S.A. 39Freeport-McMoRan Inc 35Agnico Eagle Mines Ltd 10Glencore plc 62Glencore PLC 62
Financials, valuation and price history for Tianjin TEDA Biomedical Engineering Company Limited